< Back to scientific publications

Magazine 8.37

Recurrent partial seizures with ictal yawning as atypical presentation of Hashimoto’s encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis).

Authors: S. Casciato, C. Di Bonaventura, L. Lapenta, J. Fattouch, G. Ferrazzano, M. Fanella, F. Di Fabio, M. Pasquini, M.A. Amendolea, M. Manfredi, M. Prencipe, A.T. Giallonardo

Date: 2011

Scope of interest: Epilepsy/autoimmune diseases of the CNS




You may also be interested in:

Magazine 9.54

Epileptic seizures heralding a relapse in high grade gliomas.

Authors: Di Bonaventura C, Albini M, D'Elia A, Fattouch J,Fanella M, Morano A, Lucignani G, Manfredi M, Colonnese C, Salvati M, Vanacore N, Berardelli A, Giallonardo AT.

Date: 2017

Scope of interest: Epilepsy


Read details
Magazine 2.68

Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database.

Authors: Sacco r et al

Date: 15 Feb 2023

Scope of interest: hepatological


Read details
Magazine 5.5

Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.

Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.

Date: 2020

Scope of interest: sars cov 2 therapy


Read details